CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 11 enrolled
Drug / intervention
Calcitonindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03342001
NCT03342001Phase 4Completed
CompareCT.gov

Assessing Quality of Life Changes Using Calcitonin in Patients With Hypothyroidism on Biochemical Replacement With Levothyroxine

University of Maryland, Baltimore·interventional·Posted Nov 14, 2017·Updated Feb 21, 2022

In Brief

A Phase 4 clinical trial evaluating Calcitonin for Hypothyroidism. Completed, enrolled 11 participants across 1 site.

Detailed Summary

Some people with hypothyroidism have persistent symptoms despite adequate treatment with thyroid hormones. We are testing whether giving calcitonin to such people will improve their quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypothyroidism
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedNov 14, 2017
Enrollment StartJun 18, 2018
Primary CompletionJun 30, 2019
Study CompletionAug 14, 2019
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 8.6 years ago

Interventions

Calcitonindrug

calcitonin nasal spray